Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting

Contributed by: PR Newswire

Tags

H.-Lundbeck-A/S

More Like This

Long-term treatment data for lecanemab to be presented at AAIC 2024

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

Lundbeck to share pipeline data and key insights into the progression of rare disease, Multiple System Atrophy, at International MSA Congress in Boston

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile

PR Newswire associated0

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences

Long-term lecanemab data show increased patient benefit with maintained safety profile

Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting